コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 reduced risk of disease among infants in the seroepidemiologic study.
2 raising questions about the contribution of seroepidemiologic studies.
3 ty Department of Health Services initiated a seroepidemiologic study among patients who used a free c
4 istent TWAR IgG antibody has been useful for seroepidemiologic studies and an association of TWAR IgG
5 herosclerotic cardiovascular disease by both seroepidemiologic studies and direct detection of the or
9 is review summarizes the major findings from seroepidemiologic studies in the context of other resear
10 nd atherosclerotic risk, the contribution of seroepidemiologic studies of C. pneumoniae and atheroscl
11 nt findings, and suggests a further role for seroepidemiologic studies of C. pneumoniae and atherothr
12 ic of the Congo (DRC) between 2018 and 2020, seroepidemiologic studies of vaccinated Congolese popula
14 t LCV antigens in order to perform the first seroepidemiologic study of LCV infection in New World pr
19 pel injury while working on a pig prompted a seroepidemiologic study to identify potential modes of t
22 At the population level, carefully designed seroepidemiologic studies will aid in the characterizati